Prostatis Group’s First Trust Long/Short Equity ETF FTLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.75M Buy
64,353
+3,303
+5% +$243K 1.11% 24
2026
Q1
$4.3M Buy
61,050
+1,112
+2% +$78.8K 1.1% 21
2025
Q4
$4.26M Buy
59,938
+344
+0.6% +$24.3K 1.02% 26
2025
Q3
$4.17M Buy
59,594
+4,109
+7% +$277K 1.04% 24
2025
Q2
$3.68M Sell
55,485
-6,254
-10% -$402K 1.05% 25
2025
Q1
$3.96M Sell
61,739
-7,058
-10% -$467K 1.25% 16
2024
Q4
$4.53M Buy
68,797
+4,231
+7% +$276K 1.32% 19
2024
Q3
$4.1M Buy
64,566
+5,382
+9% +$338K 1.34% 18
2024
Q2
$3.74M Buy
+59,184
New +$3.62M 1.31% 19

Other funds holding FTLS

Prostatis Group's FTLS Position: Q2 2026 in Review

Prostatis Group increased its First Trust Long/Short Equity ETF (FTLS) stake by 5.4% in Q2 2026, buying an estimated $243K and bringing the position to 64,353 shares worth $4.75M. The position accounts for 1.11% of the portfolio, ranked #24.

Prostatis Group first reported a position in FTLS in Q2 2024 and has held it in 9 quarters since. 267 funds tracked by Wall St. Rank hold FTLS as of Q2 2026.

  • Prostatis Group held 64,353 shares of First Trust Long/Short Equity ETF worth $4.75M as of Q2 2026.
  • Prostatis Group bought 3,303 First Trust Long/Short Equity ETF shares in Q2 2026, an estimated $243K.
  • First Trust Long/Short Equity ETF made up 1.11% of Prostatis Group's portfolio in Q2 2026, its #24 holding.
  • Prostatis Group first reported a position in First Trust Long/Short Equity ETF in Q2 2024 and has held it in 9 quarters since.
  • 267 funds tracked by Wall St. Rank held First Trust Long/Short Equity ETF as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.